Watson announced that ella (ulipristal acetate tablet), an oral emergency contraceptive, will be available in the fourth quarter of 2010 by prescription only. ella is a progesterone agonist/antagonist emergency contraceptive The approval of ella was based on data from clinical studies that enrolled more than 2,600 women. Among women who were administered ella within 72 hours of unprotected intercourse (UPI), the overall pregnancy rate was 1.9%, significantly lower than the anticipated pregnancy rate (5.6%). Among women who were administered ella 48–120 hours post-UPI, the overall pregnancy rate was 2.2%, significantly lower than the expected pregnancy rate (5.5%).
For more information call (800) 272-5525 or visit www.watson.com.